SFX by Ex Libris Inc.

Title:	Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
Source:	Blood [0006-4971] Didigu, Chuka yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tebas, P. "Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV." The New England journal of medicine 370.10 (2014): 901-910.
description	2.	Maier D, J. "Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease Targeted Disruption of the HIV Co-Receptor CCR5." Human gene therapy 24.3 (2013): 4294967295-258.
description	3.	"Harnessing Host Defenses to HIV." Cell 155.3 (2013): 487-489.
description	4.	Carroll, Richard G. "Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4 T cells." Science 276.5310 (1997): 273-276.
description	5.	Humphreys, R. "Trail receptors: Targets for cancer therapy." Advances in experimental medicine and biology 615.Programmed Cell Death in Cancer Progression and Therapy (2008): 127-158.
description	6.	Holmes, Perez C. "Establishment of HIV-1 resistance in CD4(+) T cells by genome editing using zinc-finger nucleases." Nature biotechnology 26.7 (2008): 808-816.
description	7.	Urnov, Fyodor D. "Genome editing with engineered zinc finger nucleases." Nature Reviews. Genetics 11.9 (2010): 636-646.
description	8.	Kay, Mark A. "Engineering cellular resistance to HIV." The New England journal of medicine 370.10 (2014): 968-969.
description	9.	Rouzioux, B. "Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study." PLOS pathogens 9.3 (2013).
description	10.	"An Aids-free World." Cell 155.3 (2013): 491-492.
description	11.	BeausÃjour, Christian M. "Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation." Molecular therapy 2 (2013).
description	12.	Hecker, James G. "Nonviral, cationic lipid-mediated delivery of mRNA." Methods in molecular biology 969 (2013): 73-88.
description	13.	Ramesh, S. V. V. "Non-coding RNAs in Crop Genetic Modification: Considerations and Predictable Environmental Risk Assessments (ERA)." Molecular biotechnology 55.1 (2013): 87-100.
description	14.	Hoxie, James A. "Novel Cell and Gene Therapies for HIV." Cold Spring Harbor perspectives in medicine 2.10 (2012).
description	15.	Accornero, P. "Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4 T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions." Blood 89.2 (1997): 558-69.
description	16.	Cathomen, T. "Zinc-finger nucleases for somatic gene therapy: the next frontier." Human gene therapy 22.8 (2011): 925-933.
description	17.	Bleul, C C C. "The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes." Proceedings of the National Academy of Sciences of the United States of America 94.5 (1997): 1925-30.
description	18.	van der Bruggen, P. "CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation." Blood 108.9 (2006): 2897-905.
description	19.	Holmes, Michael C C. "Highly efficient endogenous human gene correction using designed zinc-finger nucleases." Nature 435.7042: 646-651.
description	20.	Cannon, Paula M. "Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo." Nature Biotechnology 28.8 (2010): 839-847.